![](/img/cover-not-exists.png)
59 GM-CSF does not reduce the incidence of febrile neutropenia during combination chemotherapy for small cell lung cancer (SCLC). A west of Scotland lung cancer group trial
Milroy, R., Dorward, A., Bicknell, S., Vernon, D., Cameron, C., McGregor, K., Steward, W.Volume:
18
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(97)89338-5
Date:
August, 1997
File:
PDF, 152 KB
english, 1997